Biophysical and In Vivo Studies Identify a New Natural-Based Polyphenol, Counteracting Aβ Oligomerization In Vitro and Aβ Oligomer-Mediated Memory Impairment and Neuroinflammation in an Acute Mouse Model of Alzheimer's Disease
Abstract
In this study natural-based complex polyphenols, obtained through a smart synthetic approach, have been evaluated for their ability to inhibit the formation of Aβ 42 oligomers, the most toxic species causing synaptic dysfunction, neuroinflammation, and neuronal death leading to the onset and progression of Alzheimer’s disease. In vitro neurotoxicity tests on primary hippocampal neurons have been employed to select nontoxic candidates. Solution NMR and molecular docking studies have been performed to clarify the interaction mechanism of Aβ 42 with the synthesized polyphenol derivatives, and highlight the sterical and chemical requirements important for their antiaggregating activity. NMR results indicated that the selected polyphenolic compounds target Aβ 42 oligomeric species. Combined NMR and docking studies indicated that the Aβ 42 central hydrophobic core, namely, the 17–31 region, is the main interaction site. The length of the peptidomimetic scaffold and the presence of a guaiacol moiety were identified as important requirements for the antiaggregating activity. In vivo experiments on an Aβ 42 oligomer-induced acute mouse model highlighted that the most promising polyphenolic derivative (PP04) inhibits detrimental effects of Aβ 42 oligomers on memory and glial cell activation. NMR kinetic studies showed that PP04 is endowed with the chemical features of true inhibitors, strongly affecting both the Aβ 42 nucleation and growth rates, thus representing a promising candidate to be further developed into an effective drug against neurodegenerative diseases of the amyloid type.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A guaiacol moiety is required for anti-aggregating activity of polyphenolic inhibitors.
“a guaiacol moiety is required for the anti-aggregating activity of polyphenolic inhibitors (Tomaselli et al., 2019)”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Tomaselli et al., 2019
Cites
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · see citing works
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,815 · see citing works
Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions
Piotto, M., Saudek, V., & Sklenář, V. (1992) · Journal of Biomolecular NMR · doi:10.1007/bf02192855 · Cited by 3,720 · see citing works
HADDOCK: A Protein−Protein Docking Approach Based on Biochemical or Biophysical Information
Dominguez, C., Boelens, R., & Bonvin, A. M. J. J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja026939x · Cited by 3,187 · see citing works
LeVine, H. (1993) · Protein Science · doi:10.1002/pro.5560020312 · Cited by 2,268 · see citing works
The Immunomodulatory and Anti-Inflammatory Role of Polyphenols
Yahfoufi, N., Alsadi, N., Jambi, M., & Matar, C. (2018) · Nutrients · doi:10.3390/nu10111618 · Cited by 1,737 · see citing works
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2004) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,677 · see citing works
The Role of Polyphenols in Human Health and Food Systems: A Mini-Review
Cory, H., Passarelli, S., Szeto, J., Tamez, M., & Mattei, J. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00087 · Cited by 1,297 · see citing works
Garriques, L. N., Khurana, R., Coats, A. C., Frøkjær, S., Brange, J., Vyas, S. B., Uversky, V. N., & Fink, A. L. (2001) · Biochemistry · doi:10.1021/bi002555c · Cited by 1,178 · see citing works
Fibril structure of amyloid-β(1–42) by cryo–electron microscopy
Gremer, L., Schölzel, D., Schenk, C., Reinartz, E., Labahn, J., Ravelli, R. B. G., Tusche, M., López‐Iglesias, C., Hoyer, W., Heise, H., et al. (2017) · Science · doi:10.1126/science.aao2825 · Cited by 1,031 · see citing works
Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils
Colvin, M. T., Silvers, R., Ni, Q. Z., Can, T. V., Sergeyev, I. V., Rosay, M., Donovan, K. J., Michael, B. C., Wall, J. S., Linse, S. S., et al. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b05129 · Cited by 812 · see citing works
Solution structure of the Alzheimer amyloid β‐peptide (1–42) in an apolar microenvironment
Crescenzi, O., Tomaselli, S., Guerrini, R., Salvadori, S., D’Ursi, A. M., Temussi, P. A., & Picone, D. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03271.x · Cited by 692 · see citing works
Self-citationOno, K., Yoshiike, Y., Takashima, A., Hasegawa, K., Naiki, H., & Yamada, M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01976.x · Cited by 681 · see citing works
Mori, S., Abeygunawardana, C., Johnson, M., et al. (1995) · Journal of Magnetic Resonance Series B · doi:10.1006/jmrb.1995.1109 · Cited by 644 · see citing works
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein
Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., Tapella, L., Colombo, L., Manzoni, C., Borsello, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911829107 · Cited by 466 · see citing works
Self-citationAtomic-resolution dynamics on the surface of amyloid-β protofibrils probed by solution NMR
Fawzi, N. L., Ying, J., Ghirlando, R., Torchia, D. A., & Clore, G. M. (2011) · Nature · doi:10.1038/nature10577 · Cited by 420 · see citing works
Alzheimer's DiseasePreprint
Selkoe, D. J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004457 · Cited by 371 · see citing works
Loureiro, J. A., Andrade, S., Duarte, A., Neves, A. R., Queiroz, J. F., Nunes, C., Sevin, E., Fénart, L., Gosselet, F., Coelho, M. A. N., et al. (2017) · Molecules · doi:10.3390/molecules22020277 · Cited by 342 · see citing works
Cano, A., Ettcheto, M., Chang, J.-H., Barroso, E., Espina, M., Kühne, B. A., Barenys, M., Auladell, C., Folch, J., Souto, E. B., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.010 · Cited by 337 · see citing works
Ladiwala, A. R. A., Lin, J. C., Bale, S. S., Marcelino, A. M. C., Bhattacharya, M., Dordick, J. S., & Tessier, P. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133108 · Cited by 299 · see citing works
He, Q., Liu, J., Liang, J., Liu, X., Li, W., Zhi, L., Ding, Z., & Tuo, D. (2018) · Cells · doi:10.3390/cells7040024 · Cited by 298 · see citing works
Sinha, S., Lopes, D., Du, Z., Pang, E. S., Shanmugam, A., Lomakin, A., Talbiersky, P., Tennstaedt, A., McDaniel, K., Bakshi, R., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206279b · Cited by 280 · see citing works
Peptide dimer structure in an Aβ(1–42) fibril visualized with cryo-EM
Schmidt, M., Rohou, A. L., Lasker, K., Yadav, J. K., Schiene‐Fischer, C., Fändrich, M., & Grigorieff, N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503455112 · Cited by 219 · see citing works
Peptide-derivatized biodegradable nanoparticles able to cross the blood–brain barrier
Costantino, L., Gandolfi, F., Tosi, G., Rivasi, F., Vandelli, M. A., & Forni, F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.013 · Cited by 208 · see citing works
Ladiwala, A. R. A., Dordick, J. S., & Tessier, P. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173856 · Cited by 190 · see citing works
Prodrug Approaches for CNS Delivery
Rautio, J., Laine, K., Gynther, M., & Savolainen, J. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9009-8 · Cited by 178 · see citing works
Chen, C., Wang, Z., Zhang, Z., Liu, X., Kang, S. S., Zhang, Y., & Ye, K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718683115 · Cited by 169 · see citing works
Balducci, C., Frasca, A., Zotti, M., La Vitola, P., Mhillaj, E., Grigoli, E., Iacobellis, M., Grandi, F., Messa, M., Colombo, L., et al. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.10.012 · Cited by 164 · see citing works
Self-citationGarai, K., & Frieden, C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222478110 · Cited by 138 · see citing works
SDS Can Be Utilized as an Amyloid Inducer: A Case Study on Diverse Proteins
Khan, J. M., Qadeer, A., Chaturvedi, S. K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029694 · Cited by 129 · see citing works
A Key Role for Lysine Residues in Amyloid β-Protein Folding, Assembly, and Toxicity
Sinha, S., Lopes, D. H. J., & Bitan, G. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000247 · Cited by 126 · see citing works
Ahmed, R., VanSchouwen, B., Jafari, N., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05012 · Cited by 105 · see citing works
Hui, Y., Chengyong, T., Cheng, L., Hai-xia, H., Yuanda, Z., & Yu, W. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2421-7 · Cited by 105 · see citing works
Tosi, G., Fano, R. A., Bondioli, L., Badiali, L., Benassi, R., Rivasi, F., Ruozi, B., Forni, F., & Vandelli, M. A. (2011) · Nanomedicine · doi:10.2217/nnm.11.11 · Cited by 99 · see citing works
The protective role of plant biophenols in mechanisms of Alzheimer's disease
Omar, S. H., Scott, C., Hamlin, A. S., & Obied, H. K. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.016 · Cited by 82 · see citing works
Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models
Balducci, C., Santamaria, G., Vitola, P. L., Brandi, E., Grandi, F., Viscomi, A. R., Beeg, M., Gobbi, M., Salmona, M., Ottonello, S., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.002 · Cited by 81 · see citing works
Self-citationAlpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2
Vitola, P. L., Balducci, C., Cerovic, M., Santamaria, G., Brandi, E., Grandi, F., Caldinelli, L., Colombo, L., Morgese, M. G., Trabace, L., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.02.012 · Cited by 74 · see citing works
Self-citationMohammadi, F., Mahmudian, A., Moeeni, M., et al. (2016) · RSC Advances · doi:10.1039/c5ra18992f · Cited by 71 · see citing works
Cremades, N., & Dobson, C. M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.009 · Cited by 70 · see citing works
Rational Design of β-Sheet Ligands Against Aβ42-Induced Toxicity
Hochdörffer, K., März‐Berberich, J., Nagel‐Steger, L., Epple, M., Meyer‐Zaika, W., Horn, A. H. C., Sticht, H., Sinha, S., Bitan, G., & Schrader, T. H. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107675n · Cited by 67 · see citing works
Balducci, C., & Forloni, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990497 · Cited by 62 · see citing works
Self-citationAlgamal, M., Ahmed, R., Jafari, N., Ahsan, B., Ortega, J., & Melacini, G. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.792853 · Cited by 53 · see citing works
Galante, D., Corsaro, A., Florio, T., Vella, S., Pagano, A., Sbrana, F., Vassalli, M., Perico, A., & D’Arrigo, C. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.010 · Cited by 51 · see citing works
Self-citationGanzinger, K. A., Narayan, P. S., Qamar, S., Weimann, L., Ranasinghe, R. T., Aguzzi, A., Dobson, C. M., McColl, J. T., George‐Hyslop, P. S., & Klenerman, D. (2014) · ChemBioChem · doi:10.1002/cbic.201402377 · Cited by 49 · see citing works
Oxidized epigallocatechin gallate inhibited lysozyme fibrillation more strongly than the native form
An, T., Feng, S., & Zeng, C. (2016) · Redox Biology · doi:10.1016/j.redox.2016.12.016 · Cited by 49 · see citing works
Kantham, S., Chan, S., McColl, G., Miles, J. A., Veliyath, S. K., Deora, G. S., Dighe, S. N., Khabbazi, S., Parat, M., & Ross, B. P. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00071 · Cited by 45 · see citing works
Aggregation kinetics of the Aβ1–40 peptide monitored by NMR
Bellomo, G., Bologna, S., Gonnelli, L., Ravera, E., Fragai, M., Lelli, M., & Luchinat, C. (2018) · Chemical Communications · doi:10.1039/c8cc01710g · Cited by 44 · see citing works
Randino, R., Grimaldi, M., Persico, M., et al. (2016) · Scientific Reports · doi:10.1038/srep38846 · Cited by 38 · see citing works
Ismael, M. A., Khan, J. M., Malik, A., et al. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.06.035 · Cited by 34 · see citing works
Mohammadi, F., Moeeni, M., Mahmudian, A., et al. (2018) · Biophysical Chemistry · doi:10.1016/j.bpc.2018.02.005 · Cited by 32 · see citing works
Lambruschini, C., Galante, D., Moni, L., Ferraro, F., Gancia, G., Riva, R., Traverso, A., Banfi, L., & D’Arrigo, C. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob02182h · Cited by 26 · see citing works
Self-citationEffects of Prion Protein on Aβ42 and Pyroglutamate-Modified AβpΕ3-42 Oligomerization and Toxicity
Pagano, K., Galante, D., D’Arrigo, C., Corsaro, A., Nizzari, M., Florio, T., Molinari, H., Tomaselli, S., & Ragona, L. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1202-x · Cited by 18 · see citing works
Self-citationTrue and apparent inhibition of amyloid fibril formation
Martins, P. M. (2013) · Prion · doi:10.4161/pri.23111 · Cited by 15 · see citing works
Wälti, M. A., Libich, D. S., & Clore, G. M. (2018) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.8b01586 · Cited by 14 · see citing works
Evidence of Molecular Interactions of Aβ1–42 with N-Terminal Truncated Beta Amyloids by NMR
Tomaselli, S., Pagano, K., D’Arrigo, C., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00456 · Cited by 12 · see citing works
Self-citationModeling of chemical inhibition from amyloid protein aggregation kinetics
Vázquez, J. A. (2014) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-15-9 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Piccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., & Pannaccione, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876614 · Cited by 73 · see citing works
- Authors
- Tomaselli, S., La Vitola, P., Pagano, K., Brandi, E., Santamaria, G., Galante, D., D’Arrigo, C., Moni, L., Lambruschini, C., Banfi, L., Lucchetti, J., Fracasso, C., Molinari, H., Forloni, G., Balducci, C., & Ragona, L.
- Affiliations
- Institute for Macromolecular Studies (IT)
- Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan 20156, Italy
- Mario Negri Institute for Pharmacological Research (IT)
- Istituto per lo Studio delle Macromolecole (ISMAC), CNR, Genoa 16149, Italy
- University of Genoa (IT)
- Corresponding author
- Balducci, Claudia
- Ragona, Laura
- ORCID
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-10-11
- Volume
- 10
- Issue
- 11
- Pages
- 4462-4475
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W2979957602
- Cited by
- 29
- References
- 56
- Citations by year
- 2024: 7 · 2023: 4 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 1
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- ACS Chemical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Funders
- Alzheimer's Association (NIRG-14-321500)
- Fondazione Cariplo (2015-0503)
- Fondazione Antonio de Marco
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Keywords
- Alzheimer's disease, polyphenol derivatives, memory impairment, neuroinflammation, hippocampal neurons, guaiacol, nucleation and growth kinetics, glial activation
- MeSH terms
- Acute Disease, Alzheimer Disease, Animals, Cells, Cultured, Disease Models, Animal, Inflammation, Memory Disorders, Mice, Inbred C57BL, Peptide Fragments, Amyloid beta-Peptides, Protein Structure, Secondary, Mice, Polyphenols, Molecular Docking Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
